Effectiveness of Ankaferd BloodStopper in
Prophylaxis and Treatment of Oral Mucositis in
Childhood Cancers Evaluated with Plasma Citrulline Levels

In conclusion, our study is a prospective, clinical trial demonstrating
that ABS is effective in the prophylaxis and treatment of oral
mucositis secondary to chemotherapy in childhood cancers.
Moreover, adding ABS to SOC limits the decrease in plasma
citrulline levels. Further randomized studies with larger samples
will allow the introduction of ABS in the prophylaxis and treatment
protocols of oral mucositis.